Clinical Trial: The Efficacy and Safety of Chlorhexidine Gluconate Chip (Periochip®) in Therapy of Symptoms in Patients With Peri-implantitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: The Efficacy and Safety of Chlorhexidine Gluconate Chip (Periochip®) in Therapy of Symptoms in Patients With Peri-implantitis
Brief Summary: The purpose of the study is to assess the efficacy and the safety of Chlorhexidine Gluconate chip (Periochip®) versus Placebo Chip in treatment of symptoms in patients with Peri-Implantitis.
Detailed Summary:
Sponsor: Dexcel Pharma Technologies Ltd.
Current Primary Outcome: Mean probing pocket depth reduction
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Clinical attachment levels (CAL)
- Bleeding on probing (BOP)
Original Secondary Outcome: Same as current
Information By: Dexcel Pharma Technologies Ltd.
Dates:
Date Received: March 2, 2010
Date Started: March 2010
Date Completion:
Last Updated: November 14, 2011
Last Verified: November 2011
